
Endocrine-Disrupting Chemicals
- 1st Edition, Volume 92 - August 13, 2021
- Imprint: Academic Press
- Editors: Laura Vandenberg, Judith Turgeon
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 2 3 4 6 6 - 2
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 2 3 4 6 7 - 9
Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteAdvances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in Advances in Pharmacology series
- Updated release includes the latest information on Endocrine-Disrupting Chemicals
Investigators in neuroscience, pharmacology, neurology, psychiatry, medicine
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Endocrine disrupting chemicals: Understanding what matters
- 1 Introduction
- 2 What are EDCs?
- 3 The key characteristics of EDCs
- 4 The breadth and depth of the endocrine system
- 5 Why timing matters
- 6 Why dose matters
- 7 The consensus on EDCs
- 8 In this book
- Chapter One: Endocrine disruptor global policy
- Abstract
- 1 Introduction
- 2 Current approaches to regulating EDCs
- 3 Economic implications of EDC exposures
- 4 Conclusion
- Chapter Two: Toxicity testing and endocrine disrupting chemicals
- Abstract
- 1 Introduction
- 2 Introduction to EDC testing
- 3 Introduction to the endocrine disruptor screening program (EDSP)
- 4 In vitro screening tests
- 5 In vivo screening tests
- 6 Long-term in vivo screening tests
- 7 Improving toxicity testing for EDCs
- 8 Conclusion
- Chapter Three: Epigenetics, estrogenic endocrine-disrupting chemicals (EDCs), and the brain
- Abstract
- 1 Introduction
- 2 Hormones and sex differences in the developing brain
- 3 Endocrine-disrupting chemicals
- 4 Hormones and epigenetic mechanisms in the brain
- 5 Epigenetics and EDCs
- 6 Conclusion
- Chapter Four: Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid
- Abstract
- 1 Introduction
- 2 The EDC landscape
- 3 The emergence of the neuroendocrine disruption concept
- 4 The neuroendocrine system
- 5 Development and sexual differentiation of the neuroendocrine system
- 6 Neuroendocrine disruption of the structure and function of the HPG axis
- 7 Neuroendocrine disruption and metabolic programming
- 8 Beyond EA&T: Emerging areas of neuroendocrine disruption
- 9 Conclusion
- Conflict of interest statement
- Chapter Five: Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models
- Abstract
- 1 Introduction
- 2 Female reproductive disorders
- 3 Male reproductive disorders
- 4 Conclusion
- Conflict of interest statement
- Chapter Six: Endocrine disrupting chemicals (EDCs) and sex steroid receptors
- Abstract
- 1 Introduction
- 2 The sex steroid receptors (ERs, PRs, AR) as cellular targets for EDC action
- 3 Sex steroid receptor general MOA
- 4 EDCs that interact with SSRs
- 5 Molecular mechanisms of EDC action on sex steroid receptors
- 6 Pathological consequences of EDC action on sex steroid receptors
- 7 Conclusions
- Conflict of interest
- Chapter Seven: Endocrine disrupting chemicals and the mammary gland
- Abstract
- 1 Introduction
- 2 Overview of mammary gland biology
- 3 Lactation is important to the baby and the mother
- 4 The role of hormones in mammary gland development
- 5 Developmental origins of adult diseases
- 6 EDCs and mammary gland development
- 7 EDCs and sensitization of the mammary gland
- 8 EDCs and lactation
- 9 EDCs and gynecomastia
- 10 Conclusions
- Conflict of interest statement
- Chapter Eight: Impact of gestational exposure to endocrine disrupting chemicals on pregnancy and birth outcomes
- Abstract
- 1 Introduction
- 2 Endocrine disrupting chemicals (EDCs)
- 3 Mechanisms of EDC action during pregnancy
- 4 Modulation of EDCs effects
- 5 Long term implications of gestational EDC exposure
- 6 Limitations of available human data
- 7 Conclusion
- Chapter Nine: Endocrine disrupting chemicals (EDCs) and placental function: Impact on fetal brain development
- Abstract
- 1 Introduction
- 2 Placental formation
- 3 Placenta functions
- 4 The placenta as a neuroendocrine organ
- 5 Conclusion
- Chapter Ten: Endocrine disrupting chemicals and thyroid hormone action
- Abstract
- 1 Introduction
- 2 Thyroid hormone and development
- 3 Polychlorinated biphenyls (PCBs) and thyroid hormone
- 4 Perchlorate and thyroid hormone
- 5 Bisphenol A (BPA)
- 6 Conclusion
- Chapter Eleven: Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic
- Abstract
- 1 Introduction
- 2 Pathogenesis of type 2 diabetes mellitus
- 3 Endocrine-disrupting chemicals (EDCs)
- 4 EDCs and pathways to environmentally-mediated diabetes
- 5 EDCs and type 1 diabetes
- 6 EDCs and gestational diabetes
- 7 EDCs, diabetes disparities, and health justice
- 8 Crosstalk between clinical care and EDC exposure
- 9 Bridging the gap to address ecosystems of diabetes risk
- 10 Data gaps and the need for further studies
- 11 Conclusion
- Chapter Twelve: The new kids on the block: Emerging obesogens
- Abstract
- 1 Introduction
- 2 Adipose tissue: An overview
- 3 Obesogens, environmental factors that interfere with adipose tissue metabolism
- 4 Emerging obesogens: The new kids on the block
- 5 Approaches and reproducibility
- 6 Conclusions and future directions
- Chapter Thirteen: Endocrine disrupting chemicals and breast cancer cells
- Abstract
- 1 Introduction
- 2 EDCs as risk factors for breast cancer
- 3 Epidemiological studies of EDCs and breast cancer
- 4 EDCs and the hallmarks of cancer
- 5 The tumor microenvironment
- 6 The importance of considering long-term exposures
- 7 Epigenetic mechanisms in long-term EDC actions
- 8 Conclusion
- Chapter Fourteen: EDCs and male urogenital cancers
- Abstract
- 1 Introduction
- 2 Conclusion
- Edition: 1
- Volume: 92
- Published: August 13, 2021
- No. of pages (Hardback): 578
- No. of pages (eBook): 578
- Imprint: Academic Press
- Language: English
- Hardback ISBN: 9780128234662
- eBook ISBN: 9780128234679
LV
Laura Vandenberg
Laura Vandenberg is at School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA
Affiliations and expertise
University of Massachusetts, MA, USAJT
Judith Turgeon
Judith Turgeon is at University of California - Davis, CA, USA
Affiliations and expertise
University of California - Davis, CA, USARead Endocrine-Disrupting Chemicals on ScienceDirect